Literature DB >> 18729648

Exercise is associated with reduction in the anxiogenic effect of mCPP on acoustic startle.

James H Fox1, Sayamwong E Hammack, William A Falls.   

Abstract

Voluntary exercise has been associated with reduced anxiety across several animal models. Manipulation of central 5-HT can alter anxiety-like behaviors and administration of the 5-HT agonist metachlorophenylpiperazine (mCPP) increases anxiety in rodents and humans. To examine whether the anxiolytic effect of exercise is associated with an alteration in 5-HT systems, we examined the anxiogenic effect of mCPP in exercising and nonexercising mice. C57BL/6J mice were given 2 weeks of free access to either a functioning or nonfunctioning running wheel. Mice were then tested for acoustic startle following systemic injection of either 0, 0.1, 0.3, or 1 mg/kg of mCPP. Consistent with its anxiogenic properties, mCPP produced a dose-dependent increase in acoustic startle in nonexercising mice. However, this anxiogenic effect was blunted in exercising mice. These findings suggest that exercise may help to reduce anxiety by altering 5-HT systems, perhaps by down-regulating postsynaptic 5HT 2B/2C receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729648     DOI: 10.1037/0735-7044.122.4.943

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  27 in total

Review 1.  Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms.

Authors:  Natale R Sciolino; Philip V Holmes
Journal:  Neurosci Biobehav Rev       Date:  2012-07-05       Impact factor: 8.989

Review 2.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

3.  Individual and combined effects of physical exercise and methylphenidate on orienting behavior and social interaction in spontaneously hypertensive rats.

Authors:  Andrea M Robinson; David J Bucci
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

4.  Interpreting the effects of exercise on fear conditioning: the influence of time of day.

Authors:  Michael E Hopkins; David J Bucci
Journal:  Behav Neurosci       Date:  2010-12       Impact factor: 1.912

Review 5.  A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: Mapping the way forward.

Authors:  Geoffrey de Brouwer; Arina Fick; Brian H Harvey; De Wet Wolmarans
Journal:  Cogn Affect Behav Neurosci       Date:  2019-02       Impact factor: 3.282

Review 6.  The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse.

Authors:  Thomas Louis Kash
Journal:  Alcohol       Date:  2012-03-25       Impact factor: 2.405

Review 7.  Animal models of fear relapse.

Authors:  Travis D Goode; Stephen Maren
Journal:  ILAR J       Date:  2014

8.  Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.

Authors:  Marie M Onakomaiya; Donna M Porter; Joseph G Oberlander; Leslie P Henderson
Journal:  Horm Behav       Date:  2014-04-21       Impact factor: 3.587

9.  Exercise-associated changes in the corticosterone response to acute restraint stress: evidence for increased adrenal sensitivity and reduced corticosterone response duration.

Authors:  Brendan D Hare; Jacob A Beierle; Donna J Toufexis; Sayamwong E Hammack; William A Falls
Journal:  Neuropsychopharmacology       Date:  2013-11-26       Impact factor: 7.853

10.  Physical exercise and catecholamine reuptake inhibitors affect orienting behavior and social interaction in a rat model of attention-deficit/hyperactivity disorder.

Authors:  Andrea M Robinson; Rachel L Eggleston; David J Bucci
Journal:  Behav Neurosci       Date:  2012-10-15       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.